NovoCure (038.F) Q4 2024 Earnings

30OctConfirmed
Q4 2023
Q1 2024
Q3 2024
Q4 2024
-0.48
-0.41
-0.33
-0.26

Details

Expected EPS
-0.307389744
Actual EPS
-0.25784640000000003
Surprise EPS
0.05
Surprise Percent
+16.12%

Description

NovoCure (038.F) has reported earnings of -0.25784640000000003 per share for Q4 2024.

0 Comments

Share your thoughts